mastouille.fr est l'un des nombreux serveurs Mastodon indépendants que vous pouvez utiliser pour participer au fédiverse.
Mastouille est une instance Mastodon durable, ouverte, et hébergée en France.

Administré par :

Statistiques du serveur :

589
comptes actifs

#academicpublishers

0 message0 participant0 message aujourd’hui
Dr. Or M. Bialik<p>For the love of... I'm not sure what's worse. <a href="https://mastodon.world/tags/AcademicPublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicPublishers</span></a> are still trying to get people to order reprints in this day and age (esp. for online-only <a href="https://mastodon.world/tags/SecientificJournals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SecientificJournals</span></a>), or that someone might actually be demanding that. <br><a href="https://mastodon.world/tags/AcademicChatter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicChatter</span></a></p>
Jana Semrau<p>6 major academic publishers face antitrust lawsuit</p><p>"The <a href="https://fediscience.org/tags/lawsuit" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>lawsuit</span></a> alleges that the six <a href="https://fediscience.org/tags/academicpublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academicpublishers</span></a> have formed a “cartel” through STM, of which they are all members. Members agree to follow STM’s policies, which state that peer review is “volunteer work” and that researchers cannot submit their manuscripts to more than one journal at a time or freely share their work under review, according to the lawsuit."</p><p><a href="https://fediscience.org/tags/academicpublishing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academicpublishing</span></a> <a href="https://fediscience.org/tags/PublishOrPerish" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PublishOrPerish</span></a></p><p><a href="https://www.highereddive.com/news/6-major-academic-publishers-face-antitrust-lawsuit/727106/#:~:text=The%20class%2Daction%20lawsuit%2C%20filed,and%20Springer%20Nature%20as%20defendants" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">highereddive.com/news/6-major-</span><span class="invisible">academic-publishers-face-antitrust-lawsuit/727106/#:~:text=The%20class%2Daction%20lawsuit%2C%20filed,and%20Springer%20Nature%20as%20defendants</span></a>.</p>
Earthworm 🐌<p>Maybe something comes out of this...<br>--------------------<br>Academic Journal Publishers Antitrust Litigation</p><p>"On September 12, 2024, Lieff Cabraser and co-counsel at Justice Catalyst Law filed a federal antitrust lawsuit against six commercial publishers of academic journals, including Elsevier, Springer Nature, Taylor and Francis, Sage, Wiley, and Wolters Kluwer, on behalf of a proposed class of scientists and scholars who provided manuscripts or peer review, alleging that these publishers conspired to unlawfully appropriate billions of dollars that would otherwise have funded scientific research.</p><p>As detailed in the complaint, the defendants’ alleged scheme has three main components. First, an agreement to fix the price of peer review services at zero that includes an agreement to coerce scholars into providing their labor for nothing by expressly linking their unpaid labor with their ability to get their manuscripts published in the defendants’ preeminent journals.</p><p>Second, the publisher defendants agreed not to compete with each other for manuscripts by requiring scholars to submit their manuscripts to only one journal at a time, which substantially reduces competition by removing incentives to review manuscripts promptly and publish meritorious research quickly.</p><p>Third, the publisher defendants agreed to prohibit scholars from freely sharing the scientific advancements described in submitted manuscripts while those manuscripts are under peer review, a process that often takes over a year. As the complaint notes, “From the moment scholars submit manuscripts for publication, the Publisher Defendants behave as though the scientific advancements set forth in the manuscripts are their property, to be shared only if the Publisher Defendant grants permission. Moreover, when the Publisher Defendants select manuscripts for publication, the Publisher Defendants will often require scholars to sign away all intellectual property rights, in exchange for nothing. The manuscripts then become the actual property of the Publisher Defendants, and the Publisher Defendants charge the maximum the market will bear for access to that scientific knowledge.”</p><p>As the complaint notes, the three major elements of defendants’ scheme are each individually per se unlawful under Section 1 of the Sherman Act. NewScientist described aspects of the Scheme as “indefensible,” and the “most profitable business in the world,” explaining that the “reason it is so lucrative is because most of the costs of its content is picked up by taxpayers. Publicly funded researchers do the work, write it up and judge its merits. And yet the resulting intellectual property ends up in the hands of the publishers. To rub salt into the wound they then sell it via exorbitant subscriptions and paywalls, often paid for by taxpayers too.” Deutsche Bank aptly describes the Scheme as a “bizarre” “triple pay system” whereby “the state funds most of the research, pays the salaries of most of those checking the quality of the research, and then buys most of the published product.” As another observer explained, the Publishing Defendants’ Scheme “is as if the New Yorker or the Economist demanded that journalists write and edit each other’s work for free, and asked the government to foot the bill.”</p><p>In addition, the scheme has resulted in a variety of perverse market failures that impair the ability of scientists to do their jobs and slow dramatically the pace of scientific progress. The scheme has resulted in a worsening peer-review crisis, whereby it has become increasingly difficult to coerce busy scholars into providing their valuable labor for nothing. The Scheme has held back science, delaying advances across all fields of research. It will take longer to find effective treatments for cancer. It will take longer to make advancements in material science that will support quantum computing. It will take longer to find technological tools to combat climate change.</p><p>The lawsuit, filed in federal district court in New York, seeks treble damages and injunctive and other relief, including an order to enjoin the defendants from continuing to violate the law by requiring them to dissolve the challenged unlawful agreements."</p><p><a href="https://www.lieffcabraser.com/antitrust/academic-journals/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">lieffcabraser.com/antitrust/ac</span><span class="invisible">ademic-journals/</span></a></p><p><a href="https://kolektiva.social/tags/Elsevier" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Elsevier</span></a> <a href="https://kolektiva.social/tags/AcademicPublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicPublishers</span></a> <a href="https://kolektiva.social/tags/AcademicChatter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicChatter</span></a> <a href="https://kolektiva.social/tags/SpringerNature" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SpringerNature</span></a> <a href="https://kolektiva.social/tags/Wiley" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Wiley</span></a> <a href="https://kolektiva.social/tags/PeerReview" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PeerReview</span></a> <a href="https://kolektiva.social/tags/Sage" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Sage</span></a> <a href="https://kolektiva.social/tags/WoltersKluwer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>WoltersKluwer</span></a></p>
petersuber<p>"Why publishers are preparing to federate their sites"<br><a href="https://digiday.com/media/why-publishers-are-preparing-to-federate-their-sites/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">digiday.com/media/why-publishe</span><span class="invisible">rs-are-preparing-to-federate-their-sites/</span></a></p><p>PS: When will <a href="https://fediscience.org/tags/AcademicPublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicPublishers</span></a> start to do this? For them, it would be all gain, no loss, whether or not their works were <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>OpenAccess</span></a>. </p><p>I might not follow a <a href="https://fediscience.org/tags/publisher" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>publisher</span></a>, since too many of its works would fall outside my areas of interest. But I would definitely follow <a href="https://fediscience.org/tags/journals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>journals</span></a> and <a href="https://fediscience.org/tags/book" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>book</span></a> series. I'd also follow <a href="https://fediscience.org/tags/tags" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tags</span></a>.</p><p><a href="https://fediscience.org/tags/CurrentAwareness" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CurrentAwareness</span></a> <a href="https://fediscience.org/tags/Discoverability" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Discoverability</span></a> <a href="https://fediscience.org/tags/Fediverse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Fediverse</span></a> <a href="https://fediscience.org/tags/ScholComm" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ScholComm</span></a></p>
Roar Stovner<p><span class="h-card"><a href="https://fediscience.org/@petersuber" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>petersuber</span></a></span> On a related note, so did the Elsevier journal Neuroimaging, the top journal in its field! More details in the latest episode of the podcast Open Science Talk! <a href="https://fediscience.org/tags/openscience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>openscience</span></a> <a href="https://fediscience.org/tags/elsevier" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>elsevier</span></a> <a href="https://fediscience.org/tags/academicpublishing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academicpublishing</span></a> <a href="https://fediscience.org/tags/academicpublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academicpublishers</span></a></p>
Christina Riesenweber<p>Remember that one time when big <a href="https://openbiblio.social/tags/academicpublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academicpublishers</span></a> made fun of us for wanting good things for everyone? <a href="https://openbiblio.social/tags/openscience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>openscience</span></a> (I'm just going through my art archives and found a bunch of these)</p>
Sam Young<p><span class="h-card"><a href="https://fediscience.org/@OnNegation" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>OnNegation</span></a></span> I didn’t realise this post would get such a response. Maybe we can get some academic publishers interested in doing something if we make enough noise 😂 <a href="https://mastodonapp.uk/tags/AcademicAudio" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicAudio</span></a> <a href="https://mastodonapp.uk/tags/AudioUniversityBooks" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AudioUniversityBooks</span></a> <a href="https://mastodonapp.uk/tags/AudioAcademia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AudioAcademia</span></a> <a href="https://mastodonapp.uk/tags/AudioEducation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AudioEducation</span></a> <a href="https://mastodonapp.uk/tags/BookRevolution" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BookRevolution</span></a> <a href="https://mastodonapp.uk/tags/AcademicPublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicPublishers</span></a></p>
calamur<p>So, the Govt of India plans to roll out the "one nation one subscription " between key <a href="https://mastodon.social/tags/academicpublishers" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academicpublishers</span></a> and key research institutes and libraries from the next financial year<br>They have asked that renewals with these publishers be put on hold till the Government of India signals that it is cool to do so (once negotiations are underway</p><p><a href="https://mastodon.social/tags/THISISBIG" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>THISISBIG</span></a></p>